Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Gary Calandra

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Procedures

Anatomy

Hematopoietic Stem Cells

Phenomena

Drug Synergism

Concepts & Ideas

Disorders

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
7
Badel, Karin
7
Bridger, Gary
5
Dale, David
5
Liles, Conrad
5
MacFarland, Ronald
4
Broxmeyer, Hal
3
DiPersio, John
3
Cooper, Scott
3
Hangoc, Giao
3
Hendrix, Craig
3
Flomenberg, Neal
3
Rodger, Elin
3
Wood, Brent
3
Henson, Geoffrey
2
Flexner, Charles

Sign-in to see all Coauthors

Publications

TOP 3
DiPersio John F; Micallef Ivana N; Stiff Patrick J; Bolwell Brian J; Maziarz Richard T; Jacobsen Eric; Nademanee Auayporn; McCarty John; Bridger Gary; Calandra Gary;
Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma.
Nyunt Myaing M; Becker Stephen; MacFarland Ron T; Chee Priscilla; Scarborough Robert; Everts Stephanie; Calandra Gary B; Hendrix Craig W
Pharmacokinetic effect of AMD070, an Oral CXCR4 antagonist, on CYP3A4 and CYP2D6 substrates midazolam and dextromethorphan in healthy volunteers.
Calandra G; McCarty J; McGuirk J; Tricot G; Crocker S-A; Badel K; Grove B; Dye A; Bridger G
AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Gary Calandra (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: DiPersio John F; Micallef Ivana N; Stiff Patrick J; Bolwell Brian J; Maziarz Richard T; Jacobsen Eric; Nademanee Auayporn; McCarty John; Bridger Gary; Calandra Gary;
Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4767-73.
2008: Nyunt Myaing M; Becker Stephen; MacFarland Ron T; Chee Priscilla; Scarborough Robert; Everts Stephanie; Calandra Gary B; Hendrix Craig W
Pharmacokinetic effect of AMD070, an Oral CXCR4 antagonist, on CYP3A4 and CYP2D6 substrates midazolam and dextromethorphan in healthy volunteers.
Journal of acquired immune deficiency syndromes (1999) 2008;47(5):559-65.
2008: Calandra G; McCarty J; McGuirk J; Tricot G; Crocker S-A; Badel K; Grove B; Dye A; Bridger G
AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data.
Bone marrow transplantation 2008;41(4):331-8.
2007: Gazitt Yair; Freytes Cesar O; Akay Cagla; Badel Karin; Calandra Gary
Improved mobilization of peripheral blood CD34+ cells and dendritic cells by AMD3100 plus granulocyte-colony-stimulating factor in non-Hodgkin's lymphoma patients.
Stem cells and development 2007;16(4):657-66.
2007: Stone Nimalie D; Dunaway Shelia B; Flexner Charles; Tierney Camlin; Calandra Gary B; Becker Stephen; Cao Ying-Jun; Wiggins Ilene P; Conley Jeanne; MacFarland Ron T; Park Jeong-Gun; Lalama Christina; Snyder Sally; Kallungal Beatrice; Klingman Karin L; Hendrix Craig W
Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects.
Antimicrobial agents and chemotherapy 2007;51(7):2351-8.
2006: Fruehauf Stefan; Seeger Timon; Maier Patrick; Li Li; Weinhardt Stephan; Laufs Stephanie; Wagner Wolfgang; Eckstein Volker; Bridger Gary; Calandra Gary; Wenz Frederick; Zeller W Jens; Goldschmidt Hartmut; Ho Anthony D
The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics.
Experimental hematology 2006;34(8):1052-9.
2005: Flomenberg Neal; Devine Steven M; Dipersio John F; Liesveld Jane L; McCarty John M; Rowley Scott D; Vesole David H; Badel Karin; Calandra Gary
The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.
Blood 2005;106(5):1867-74.
2005: Lack N A; Green B; Dale D C; Calandra G B; Lee H; MacFarland R T; Badel K; Liles W C; Bridger G
A pharmacokinetic-pharmacodynamic model for the mobilization of CD34+ hematopoietic progenitor cells by AMD3100.
Clinical pharmacology and therapeutics 2005;77(5):427-36.
2005: Broxmeyer Hal E; Orschell Christie M; Clapp D Wade; Hangoc Giao; Cooper Scott; Plett P Artur; Liles W Conrad; Li Xiaxin; Graham-Evans Barbara; Campbell Timothy B; Calandra Gary; Bridger Gary; Dale David C; Srour Edward F
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
The Journal of experimental medicine 2005;201(8):1307-18.
2005: Liles W Conrad; Rodger Elin; Broxmeyer Hal E; Dehner Christine; Badel Karin; Calandra Gary; Christensen Jeff; Wood Brent; Price Thomas H; Dale David C
Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist.
Transfusion 2005;45(3):295-300.
2005: Flomenberg Neal; DiPersio John; Calandra Gary
Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells.
Acta haematologica 2005;114(4):198-205.
2004: Hendrix Craig W; Collier Ann C; Lederman Michael M; Schols Dominique; Pollard Richard B; Brown Stephen; Jackson J Brooks; Coombs Robert W; Glesby Marshall J; Flexner Charles W; Bridger Gary J; Badel Karin; MacFarland Ronald T; Henson Geoffrey W; Calandra Gary;
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2004;37(2):1253-62.
2004: Hübel Kai; Liles W Conrad; Broxmeyer Hal E; Rodger Elin; Wood Brent; Cooper Scott; Hangoc Giao; Macfarland Ron; Bridger Gary J; Henson Geoffrey W; Calandra Gary; Dale David C
Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 Antagonist.
Supportive cancer therapy 2004;1(3):165-72.
2004: Devine Steven M; Flomenberg Neal; Vesole David H; Liesveld Jane; Weisdorf Daniel; Badel Karin; Calandra Gary; DiPersio John F
Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):1095-102.
2003: Liles W Conrad; Broxmeyer Hal E; Rodger Elin; Wood Brent; Hübel Kai; Cooper Scott; Hangoc Giao; Bridger Gary J; Henson Geoffrey W; Calandra Gary; Dale David C
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist.
Blood 2003;102(8):2728-30.

Sign-in to see more